van den Bosch Gerbrich E, Tibboel Dick, de Graaff Jurgen C, El Marroun Hanan, van der Lugt Aad, White Tonya, van Dijk Monique
Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.
Division of Neonatology, Department of Pediatrics, Erasmus Medical Center (MC)-Sophia Children's Hospital, Rotterdam, Netherlands.
Front Pediatr. 2022 May 11;10:825725. doi: 10.3389/fped.2022.825725. eCollection 2022.
To evaluate possible negative long-term effects of neonatal exposure to pain, opioids and anesthetics in children and adolescents.
We studied five unique groups of children recruited from well-documented neonatal cohorts with a history of neonatal exposure to pain, opioids or anesthetics at different points along the continuum from no pain to intense pain and from no opioid exposure to very high opioid exposure in the presence or absence of anesthetics. We evaluated children who underwent major surgery (group 1 and 2), extracorporeal membrane oxygenation (group 3), preterm birth (group 4) and prenatal opioid exposure (group 5) in comparison to healthy controls. Neuropsychological functioning, thermal detection and pain thresholds and high-resolution structural and task-based functional magnetic resonance imaging during pain were assessed. In total 94 cases were included and compared to their own control groups.
Children and adolescents in groups 3 and 5 showed worse neuropsychological functioning after high opioid exposure. A thicker cortex was found in group 1 (pain, opioid and anesthetic exposure) in only the left rostral-middle-frontal-cortex compared to controls. We found no differences in other brain volumes, pain thresholds or brain activity during pain in pain related brain regions between the other groups and their controls.
No major effects of neonatal pain, opioid or anesthetic exposure were observed in humans 8-19 years after exposure in early life, apart from neuropsychological effects in the groups with the highest opioid exposure that warrants further investigation. Studies with larger sample sizes are needed to confirm our findings and test for less pronounced differences between exposed and unexposed children.
评估新生儿暴露于疼痛、阿片类药物和麻醉剂对儿童及青少年可能产生的长期负面影响。
我们研究了五组独特的儿童群体,这些儿童来自记录完备的新生儿队列,在从无疼痛到剧烈疼痛、从无阿片类药物暴露到极高阿片类药物暴露的连续过程中的不同时间点,有新生儿暴露于疼痛、阿片类药物或麻醉剂的经历,且暴露过程中有无麻醉剂使用情况。我们将接受大手术的儿童(第1组和第2组)、体外膜肺氧合治疗的儿童(第3组)、早产儿童(第4组)和产前暴露于阿片类药物的儿童(第5组)与健康对照组进行比较。评估了神经心理功能、热觉检测和疼痛阈值,以及疼痛期间的高分辨率结构和基于任务的功能磁共振成像。总共纳入了94例病例,并与各自的对照组进行比较。
第3组和第5组的儿童及青少年在高剂量阿片类药物暴露后神经心理功能较差。与对照组相比,第1组(疼痛、阿片类药物和麻醉剂暴露组)仅在左侧额中回喙部皮质发现皮质更厚。我们发现其他组及其对照组在其他脑容量、疼痛阈值或疼痛相关脑区疼痛期间的脑活动方面没有差异。
在生命早期暴露后8至19年的人类中,未观察到新生儿疼痛、阿片类药物或麻醉剂暴露产生的重大影响,但阿片类药物暴露量最高的组中出现的神经心理影响值得进一步研究。需要更大样本量的研究来证实我们的发现,并检测暴露组和未暴露组儿童之间不太明显的差异。